Skip to content

Correlation of ceramide with acute ischemic stroke prognosis

Correlation of ceramide with acute ischemic stroke prognosis

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092730
Enrollment
Unknown
Registered
2024-11-21
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke

Interventions

Recurrence of stroke vs. No recurrence:NA

Sponsors

Beijing Daxing District People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) Age>= 18 years old; (2) New cerebral infarction confirmed by CT or MRI of the head after admission; (3) within 7 days of onset to enrollment; (4) The patient or the patient's legal representative signs the informed consent form.

Exclusion criteria

Exclusion criteria: (1) CT of the head suggests intracranial hemorrhagic disorder; (2) severe renal and/or hepatic insufficiency; (3) Patients with severe edema, known malignancy or autoimmune disease and severe infection; (4) Patients who are receiving steroid therapy at the time of blood collection; (5) pregnant or lactating women; (6) Unable to complete the study for other reasons or the investigator unanimously believes that it is not suitable for enrollment in the investigator

Design outcomes

Primary

MeasureTime frame
stroke recurrence at 90 +/- 7day;modified Rankin Score at 90 +/- 7day;

Secondary

MeasureTime frame
Combined vascular events (stroke, myocardial infarction, cardiovascular death);Adverse Events/Serious Adverse Events;

Countries

China

Contacts

Public ContactChunmiao Duan

Beijing Daxing District People's Hospital

miao3252003@163.com+86 138 1039 0305

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026